How to Buy Rapamycin: Prescription, Cost & Dosing

Rapamycin is the only drug in the world that has reliably extended lifespan across multiple species in multiple independent laboratories. Mice, flies, worms, yeast. It works in all of them. And unlike most compounds sitting on supplement shelves, the mechanism is well understood, rigorously tested, and highly conserved across biology.

So it's no surprise that more people than ever are asking the same question: how do you actually buy it?

This isn't as straightforward as ordering NMN from Amazon. Rapamycin is prescription-only in the US. But it's not a controlled substance, and off-label prescribing is completely legal. That means if you find the right physician, you can access it. The rise of longevity-focused telehealth in the past few years has made this easier, faster, and cheaper than it's ever been.

This guide covers everything you need to know: what rapamycin is, whether purchasing it is legal, how to get a prescription through telehealth or an in-person doctor, what it actually costs without insurance (the answer is less than you'd think), what bloodwork you need before and during treatment, how to dose it for longevity rather than transplant medicine, what side effects to watch, and how to spot the red flags that tell you an online source isn't legitimate.

What is rapamycin?

Rapamycin, generically called sirolimus, is a macrolide compound discovered in the 1970s in soil bacteria on Easter Island. The island's indigenous name is Rapa Nui, which is how the drug got its name. Researchers initially looked at it as an antifungal. Then as an immunosuppressant. The FDA approved it in 1999 to prevent organ rejection in kidney transplant patients. It's also approved for a rare lung disease called lymphangioleiomyomatosis and for treating certain rare cancers.

But the longevity field's interest in rapamycin is entirely different. It's about mTOR.

How mTOR drives aging

mTOR stands for mechanistic Target of Rapamycin, and it's a protein complex that functions as the cell's master growth regulator. It integrates signals about nutrient availability, energy status, growth factors, and stress, and it responds by either pushing the cell toward growth and protein synthesis or pulling back and initiating maintenance processes.

When nutrients are abundant, mTOR activates and drives growth. That's appropriate when you're young, building tissue, recovering from exercise, healing injuries. But as we age, chronically elevated mTOR activity becomes a liability.

Here's what goes wrong when mTOR runs hot for too long. The cellular cleanup process called autophagy gets suppressed. Autophagy is how cells break down damaged proteins, dysfunctional organelles, and misfolded aggregates that accumulate over decades. When it slows, cellular junk builds up. Mitochondria become inefficient but aren't recycled. Protein aggregates accumulate in neurons, which is why mTOR dysregulation is implicated in Alzheimer's and Parkinson's disease pathology.

Senescent cells, the "zombie cells" that stop dividing but refuse to die, multiply with age. They secrete a cocktail of inflammatory signals called the SASP, the senescence-associated secretory phenotype, which damages surrounding tissue and drives chronic systemic inflammation. Chronic mTOR activity promotes the SASP and makes the senescent cell problem worse.

Rapamycin inhibits mTOR. Specifically, it binds an intracellular protein called FKBP12, and that complex directly inhibits mTORC1, one of the two mTOR complexes. When you take rapamycin, mTOR activity drops, autophagy turns back on, cellular housekeeping resumes, and the senescent cell environment improves.

This mechanism doesn't target just one hallmark of aging. It touches several simultaneously: impaired autophagy, cellular senescence, mitochondrial dysfunction, altered nutrient sensing, and deregulated inflammatory signaling. That's the reason rapamycin gets more serious attention from longevity researchers than most other compounds. It acts at a more fundamental regulatory level.

The science: what does the research actually show?

Let's be honest about where the evidence stands, because the animal data and the human data tell meaningfully different stories. Both matter for making an informed decision.

The mouse data that changed everything

The NIA Interventions Testing Program is the most rigorous preclinical longevity drug testing program in existence. It runs simultaneously at three independent research centers, using genetically diverse mice that better approximate human genetic variation than inbred laboratory strains. In 2009, the ITP published results that stopped the longevity research community cold.

Rapamycin extended median lifespan in mice by 14% in females and 9% in males. Impressive enough. But the result that made this historic was the starting point: the mice didn't begin rapamycin until they were 270 days old, roughly equivalent to a 60-year-old human. The drug extended life even when started well into old age.

This result has been replicated and extended across multiple experiments. Rapamycin is the only intervention in the ITP's history to consistently extend lifespan in genetically diverse mice when started late in life. And it's not just mice. Rapamycin extends lifespan in flies, worms, and yeast. The cross-species consistency is as close to a biological signal as this field has ever produced. The same molecular pathway, mTOR, regulates longevity across the entire evolutionary tree of life.

The PEARL trial: most important human data to date

No large-scale human trial has shown rapamycin extends human lifespan. Those trials simply haven't been done at the scale or timeline required. But the most meaningful human data comes from the PEARL trial, run by AgelessRx, which enrolled 114 healthy participants aged 50-85 in a 48-week, double-blinded, placebo-controlled study testing 5mg/week and 10mg/week against placebo.

The results: weekly pulse dosing was safe over 48 weeks. Blood biomarkers stayed within normal ranges. Women on 10mg/week showed significant improvements in lean tissue mass, pain scores, social functioning, and osteoarthritis scores. Men showed improved bone mineral content. Adverse events were similar between treatment and placebo groups.

This isn't a lifespan trial. But it's meaningful evidence that weekly pulse dosing doesn't produce the serious harms associated with daily transplant-level dosing, and it produces measurable healthspan improvements at well-tolerated doses.

What the experts actually think

Peter Attia, MD, has been taking rapamycin himself for years and prescribes it to a carefully selected subset of his patients. His view is measured: the preclinical evidence is compelling, daily versus weekly dosing produces fundamentally different physiological effects, and the decision to use rapamycin should be made within a proper clinical framework with baseline labs and ongoing monitoring. He's explicit that no human trial has proven lifespan extension. He's also explicit that the absence of that evidence doesn't mean it won't extend human lifespan.

Matt Kaeberlein at the University of Washington, who co-founded the Dog Aging Project testing rapamycin in companion dogs as a translational model, regularly discusses rapamycin as the most promising pharmacological geroprotector currently available. His position: the data in model organisms is extraordinary, the human safety profile at longevity doses looks acceptable, and waiting for definitive human lifespan trials before making a personal decision means waiting decades.

WinAging covers rapamycin in the context of the broader longevity stack. Before building any protocol involving prescription compounds, use the supplement interaction checker to flag CYP3A4 interactions and make sure your full stack is safe. Rapamycin has real drug interactions that matter.

Is it legal to buy rapamycin?

Yes, with a prescription. And the full picture is more accessible than most people expect.

Rapamycin is not a controlled substance under DEA scheduling. It sits in a completely different category from opioids, benzodiazepines, or stimulants. There's no DEA scheduling around it. But it is prescription-only under FDA regulations, meaning you can't legally purchase it at a pharmacy without a valid prescription from a licensed US physician.

Off-label prescribing is completely legal in the US. Physicians can prescribe any FDA-approved drug for any purpose they judge medically appropriate, regardless of whether the FDA has approved it for that specific indication. The FDA approves labels for manufacturers, not for physicians. Longevity isn't an FDA-approved indication for rapamycin. That doesn't prevent any physician from writing a prescription for it. Doctors prescribe rapamycin off-label for longevity every day at telehealth platforms and specialty clinics across the country.

Insurance almost never covers rapamycin for anti-aging use. Transplant patients get coverage. For longevity purposes, insurance will decline. You're paying out of pocket. We'll cover exactly what that costs below.

One other note: technically importing rapamycin from overseas without a US prescription is illegal, though enforcement for personal-use quantities is inconsistently applied. The more serious problem with offshore sources isn't legal risk, it's quality and authenticity, which is its own section below.

How to get a rapamycin prescription

There are two realistic routes: telehealth platforms and in-person longevity medicine physicians. For most people, telehealth is the fastest and most practical starting point.

Telehealth platforms: fastest access

Longevity-focused telehealth has grown dramatically. These platforms connect you with physicians who are specifically experienced with off-label rapamycin protocols and who follow evidence-based monitoring standards. This isn't a concierge service for the ultra-wealthy anymore.

AgelessRx was one of the first platforms to offer rapamycin at scale and funded the PEARL trial. Initial consultations are free, with starting prices around $65/month including medication. Baseline bloodwork is mandatory before prescribing, and ongoing labs are required for refills. They're not operating in every state for every formulation, with restrictions on some versions in NY, NJ, and RI, but they serve most of the country.

Healthspan (GetHealthspan) starts at around $64/month with labs included. Their protocol includes detailed aging analysis alongside the rapamycin prescription. Physicians work through independently owned practices on their telehealth platform.

Heally connects patients with longevity doctors across the country. Free initial consultation, monthly subscription of around $149 after physician approval. HSA and FSA eligible. Medication ships to your door.

Finding an in-person physician

Some people prefer working with an in-person physician who can monitor them closely, discuss the protocol in depth, and manage any complications directly. The types of doctors most likely to be familiar with off-label rapamycin: functional medicine physicians, integrative medicine practitioners, longevity medicine specialists, and forward-looking internists or geriatricians who follow the research.

The late Dr. Alan Green, a Queens, NY internist who passed away in September 2024, was the most prominent example. He treated over 1,500 patients with rapamycin for longevity, charged $350 for an initial visit, didn't take insurance, and had patients traveling from across the country. His clinical documentation and public advocacy helped normalize this use case for the broader medical community. His website, rapamycintherapy.com, remains a resource.

Finding a comparable physician requires some work. The rapamycin.news forum maintains active community discussions about locating prescribing physicians by state. Functional medicine directories list practitioners by specialty. The key in any conversation with a potential prescriber: confirm they're familiar with the PEARL trial and with the distinction between daily and pulse dosing.

What to expect at a first appointment

Whether you go telehealth or in-person, the process follows a similar pattern.

You'll complete a detailed health intake: medical history, current medications, existing conditions, and your goals. Most platforms want bloodwork ordered before or at the time of your first appointment. The appointment itself runs 20-45 minutes with a physician who reviews your labs, discusses the evidence base, explains that this is off-label use, and assesses whether you're a candidate.

If you're approved, your prescription goes to a US-licensed pharmacy or compounding pharmacy. Medication arrives by mail. Follow-ups are typically quarterly, with bloodwork required before refills.

Most platforms set a minimum age of 40, require you to be clinically stable, ask that you not be pregnant or trying to conceive, and require a commitment to ongoing monitoring. If you're outside those parameters, the conversation is still worth having with the physician. Clinical situations vary.

Good questions to ask at your first appointment: What dose do you recommend starting at, and how do you titrate? What bloodwork schedule do you follow? Do you check rapamycin blood levels, and when? What should I watch for in the first 4 weeks? What interactions should I be aware of given my current medications?

Arriving at that appointment informed makes it more productive. Understanding where the science sits, what the PEARL trial found, and what responsible pulse dosing looks like signals that you're a serious patient who will follow the protocol and report back accurately.

How much does rapamycin cost?

Less than you probably think, once you know which channels to use. The brand-name version (Rapamune, made by Pfizer) is extraordinarily expensive at retail. Generic sirolimus at standard pharmacy list prices is also steep. But nobody pays list price.

Cash pricing without insurance

Brand-name Rapamune retails for roughly $1,000-1,400 for 30 x 1mg tablets. You won't be paying this.

Generic sirolimus at retail pharmacy list prices runs around $491 for 30 x 1mg tablets. Still alarming. Still not what most people pay.

GoodRx brings generic sirolimus 1mg down to approximately $66-110 for 30 tablets at major US pharmacy chains, depending on which chain and which specific coupon. At a typical longevity dose of 5mg once per week, you're using roughly 4-5 tablets per month. That puts actual drug cost at around $12-20/month with GoodRx.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) prices drugs at manufacturing cost plus a 15% markup plus a $3 pharmacy fee. They carry generic sirolimus in 0.5mg, 1mg, and 2mg tablet formulations. Pricing is typically even lower than GoodRx. A valid prescription is required to purchase. This is a completely legitimate, NABP-compliant pharmacy.

Amazon Pharmacy with Prime membership offers generic sirolimus on 90-day supply at roughly $4.25 per 1mg tablet.

Compounding pharmacies

Some physicians prescribe compounded rapamycin, particularly when they want doses not available in commercial tablet form, like 3mg, 5mg, or 6mg capsules. Pharmacies like Tailor Made Health and Empower Pharmacy offer custom formulations. Expect around $100-120/month for a 30-capsule supply of 3mg or 5mg compounded capsules. The advantage of compounding is dose flexibility. The disadvantage is higher cost.

Telehealth platform pricing

The platforms bundle physician consultation, lab monitoring, and medication into a monthly price. AgelessRx and Healthspan start around $64-65/month. Heally runs around $149/month. The premium over buying generic via GoodRx reflects the ongoing physician oversight, which is genuinely valuable when you're managing a drug that requires bloodwork monitoring, dose titration, and someone to contact if side effects appear.

For most people starting out, a telehealth platform makes sense: you get structured monitoring, a physician who knows the protocol, and built-in lab scheduling. Once you've been on a stable dose for a year or two and have an established relationship with a physician willing to provide ongoing care, the economics of a standalone prescription via GoodRx or Cost Plus Drugs become more attractive.

To compare rapamycin's cost against other longevity interventions and build out your full protocol budget, the free tools at WinAging can help you structure this. The biological age calculator also gives you a measurable baseline to assess whether your protocol is working over time.

What bloodwork do you need?

No legitimate prescriber will start you on rapamycin without a baseline panel, and that's not bureaucratic caution. It's clinically meaningful. Rapamycin affects lipid metabolism and glucose regulation in ways that depend heavily on your starting point. The baseline panel determines whether you're a good candidate and gives you the numbers to compare against during ongoing monitoring.

Required baseline tests

Fasting lipid panel: Total cholesterol, LDL, HDL, and triglycerides. Rapamycin can raise LDL and triglycerides, particularly at higher doses. This is the most consistently observed metabolic side effect. You need to know your starting point before attributing any change to the drug.

Fasting glucose and HbA1c: Rapamycin inhibits mTORC2 at sustained elevated concentrations, which can impair insulin signaling and raise blood glucose. At weekly pulse doses in metabolically healthy people, this effect is much milder than at daily transplant doses, but if your baseline HbA1c is already at 5.7 or above, that context matters to your prescriber's decision.

Complete blood count: White blood cells, red blood cells, and platelets. Standard baseline for any drug with potential immune effects. At longevity pulse doses, meaningful immune suppression is uncommon, but the baseline matters for interpretation.

Comprehensive metabolic panel: Liver enzymes (ALT, AST, ALP) and kidney function (creatinine, BUN). Rapamycin is metabolized hepatically and has historical associations with nephrotoxicity at transplant-level daily doses. At longevity doses, significant kidney or liver effects are rare, but baseline values let you interpret any future changes accurately.

Your prescriber will also review your full medication list carefully, because rapamycin is metabolized through the CYP3A4 enzyme pathway and interacts with dozens of common drugs. Many antibiotics, antifungals, some statins, and even grapefruit juice can significantly raise or lower rapamycin blood levels.

Ongoing monitoring schedule

During initial dose titration, expect bloodwork every 6-12 weeks. Once you've been stable on a maintenance dose for several months, every 3-6 months is typical. Some physicians also periodically check sirolimus blood trough levels, a test available through Quest Diagnostics and other major labs. The trough level tells you exactly how much drug is circulating in your system. It's useful for personalizing dosing, because rapamycin bioavailability varies significantly between people depending on gut absorption differences and body composition.

The Healthspan platform specifically offers a "Rapamycin Bioavailability Panel" designed around this monitoring approach. This level of personalization is one of the legitimate arguments for using a structured telehealth platform rather than just getting a standalone prescription.

Longevity dosing: why weekly beats daily

This is the most important conceptual shift for anyone who's read about rapamycin in the context of transplant medicine and found the side effect profile alarming. Transplant-level dosing and longevity dosing are, in practice, different drugs.

Transplant patients take 1-5mg of rapamycin daily to maintain chronic immunosuppression. That produces the side effects you've probably read about: significant immune suppression, elevated infection risk, serious lipid abnormalities, glucose intolerance, impaired wound healing. Those effects are real and clinically documented at daily dosing.

Longevity users take rapamycin once weekly at higher individual doses, typically 5-7mg. The weekly gap allows mTOR activity to recover between doses. Protein synthesis, immune surveillance, and normal cellular function continue throughout the week. You get the mTOR inhibition signal, the autophagy activation, and the cellular reset, without the chronic suppression that causes transplant-level problems.

Why does this work mechanistically? mTOR signaling recovers within 24-72 hours after a single pulse. The cellular effects of that inhibition, particularly autophagy activation, persist longer than the drug's direct action. So the weekly approach gives you the therapeutic signal while giving the body time to normalize. It also avoids sustained mTORC2 inhibition, which is how daily rapamycin causes insulin resistance.

Typical longevity dosing protocol

Most physicians start conservatively: 1-3mg once per week for the first 4-8 weeks, watching for any side effects and getting a first follow-up lab panel. Then they titrate up, typically by 1mg increments every 4-8 weeks, based on tolerance, bloodwork findings, and the prescriber's clinical judgment.

The most commonly used maintenance doses run between 5-7mg once per week. The PEARL trial tested 5mg/week and 10mg/week against placebo. Both produced measurable effects. The 10mg arm produced stronger results but also more side effects. Most longevity physicians land between 5 and 6mg/week as a practical maintenance target for healthy adults.

Some practitioners use a cycling approach: 3 months on, 1 month off. The reasoning is that periodic breaks prevent any adaptation effects and give the body time to fully normalize. The evidence specifically comparing cycling versus continuous weekly dosing in humans is limited, and different physicians have different approaches. It's worth discussing with your prescriber.

What doesn't work: trying to replicate a transplant protocol because it sounds more "clinical" or more aggressive. Daily dosing at 1-2mg does not produce the same longevity signal as weekly dosing at 5mg. They're mechanistically different regimens with different effects on mTORC1 versus mTORC2 inhibition.

Side effects and what to watch

Weekly pulse dosing is well tolerated by most people, but side effects do occur and some require attention. Knowing what to watch for and what to do about it makes the whole experience much more manageable.

Mouth sores and oral ulcers are the most commonly reported complaint at longevity doses. They typically appear in the first 2-4 weeks and improve or resolve for most people with time or dose adjustment. Salt water rinses 2-3 times per day help. Some people report improvement with sublingual vitamin B12 supplementation. If sores are severe, persistent, or interfere with eating, talk to your prescriber about adjusting the dose or timing.

Elevated lipids: LDL cholesterol and triglycerides can rise, particularly during the first weeks on rapamycin. This is the most clinically important metabolic side effect to monitor, because it's measurable, dose-dependent, and consistent enough that your 6-week lipid panel is a meaningful data point. Some physicians address clinically significant lipid elevation with berberine as a first-line approach before reaching for a statin. Berberine supplements have independent evidence for mTOR modulation and LDL-lowering effects, which makes them a logical companion in a rapamycin protocol.

Impaired wound healing: mTOR signaling is required for proper tissue repair. Rapamycin slows this process. If you have elective surgery planned, pause rapamycin at least 2 weeks before the procedure and resume 2-3 weeks after full healing. Tell any surgeon you're taking it, because wound dehiscence is a documented risk with ongoing rapamycin use around surgical procedures.

Drug interactions via CYP3A4: This is the interaction risk most people underestimate. Rapamycin's metabolism depends heavily on CYP3A4. Any drug or supplement that inhibits this enzyme, including certain antibiotics like clarithromycin, antifungals like fluconazole, some calcium channel blockers, and even grapefruit, raises rapamycin blood levels significantly. Enzyme inducers like rifampin or St. John's Wort drop rapamycin levels. Use the supplement interaction checker at WinAging to flag anything in your current stack that might affect rapamycin metabolism before starting.

Glucose effects: At weekly pulse doses in metabolically healthy people, clinically significant glucose impairment is uncommon. The mTORC2 inhibition pathway that drives insulin resistance at daily doses isn't chronically engaged with weekly dosing. But if your baseline HbA1c is already elevated, or if you're managing prediabetes, discuss this specifically with your prescriber. Pairing rapamycin with a berberine-based supplement, which improves insulin sensitivity through AMPK activation, is a strategy some physicians use to offset any mild metabolic effects. The berberine and inositol combination is particularly relevant for anyone with metabolic concerns.

Temporary fatigue or malaise: Some people report mild fatigue in the first few weeks. This typically resolves and is not a reason to stop unless it's severe or persistent.

Who shouldn't take rapamycin

Anyone pregnant or planning to conceive in the near term. Rapamycin is teratogenic, meaning it can cause fetal abnormalities, and it requires a full 12-week washout period before attempting conception.

Anyone with active serious infections. Rapamycin has some immune-modulating effects even at pulse doses, and active infections require your immune system operating at full capacity.

Anyone with severe kidney or liver disease, because these organs are central to rapamycin's metabolism and clearance.

Anyone with surgery planned within 4-6 weeks.

If you're already taking low-dose naltrexone, another widely used off-label longevity prescription compound, discuss managing both with your physician. Multiple prescription longevity compounds require coordinated management and ideally a physician who understands the full picture.

Red flags: avoiding sketchy sources

You'll find rapamycin for sale on Indian pharmacy websites, Chinese online pharmacies, various gray-market forums, and sources that claim no prescription is required. The prices look attractive. Some run as low as $1 per tablet with free international shipping.

Don't use them.

The quality problem is well-documented in the longevity community. Users at rapamycin.news and related forums have described escalating their doses from offshore sources because they felt no effects, then getting a rapamycin trough blood level test at Quest Diagnostics and finding zero detectable drug in their system. The capsules they purchased weren't rapamycin. The product was either a completely different compound, an inactive filler, or so severely underdosed as to be meaningless. Without a blood level test, you'd have no way to know.

There's also the legal risk. The DOJ has prosecuted networks for manufacturing and distributing counterfeit pharmaceuticals through illegal online pharmacies, with multiple deaths attributed to these operations.

What legitimate sources look like: NABP-verified "VIPPS" seal (Verified Internet Pharmacy Practice Sites), which you can confirm at nabp.pharmacy. Requires a valid prescription from a licensed US physician before dispensing. Has a licensed pharmacist reachable by phone. Has a verifiable US physical address. Prices that reflect actual generic drug economics (not $1/tablet).

Mark Cuban's Cost Plus Drugs, Amazon Pharmacy with Prime, GoodRx-partnered major chains like Walgreens, CVS, and Costco pharmacy, and compounding pharmacies like Empower Pharmacy and Tailor Made Health are all legitimate, transparent sources. Use these.

Any telehealth platform that offers to prescribe rapamycin without requiring baseline bloodwork is another red flag. The blood panel isn't optional. It's the clinical foundation of a responsible protocol. If a platform wants to skip it, that's not a physician you want managing your medication.

Building your rapamycin stack

Rapamycin doesn't exist in isolation for most people serious about longevity. It's typically the anchor of a broader protocol that targets multiple aging pathways simultaneously.

The compounds that pair well with rapamycin, based on mechanism and practitioner experience:

Berberine or metformin: Both activate AMPK, which works in concert with mTOR inhibition on the nutrient-sensing axis of aging. Berberine is accessible without a prescription, has its own evidence for longevity and metabolic benefits, and also modestly lowers LDL, which can help offset rapamycin's lipid effects. The best berberine supplement guide covers what to look for in a quality product. Berberine synergy formulations often combine berberine with complementary compounds for enhanced metabolic effects. And for those with blood sugar concerns, the berberine and alpha-lipoic acid combination provides additional insulin sensitivity support.

NAD+ precursors (NMN or NR): Support mitochondrial function through the sirtuin pathway, which is complementary to rather than redundant with mTOR inhibition. The resveratrol vs NMN debate gives useful context on where these sit in the stack hierarchy. If you've considered NMN and want perspective on the skeptical side, why some people stopped taking NMN is worth reading before you commit to that part of the protocol.

Glycine and GlyNAC: Support cellular redox balance and glutathione levels. Independent anti-aging evidence in clinical trials of older adults. Read about glycine dosing for longevity if you want to add this. For methylation support alongside NMN, TMG is a frequently paired compound worth understanding.

Creatine: Often overlooked as a longevity compound, but has good evidence for preserving muscle mass and cognitive function with age. If you're evaluating forms, the instantized creatine breakdown explains the differences. The creatine calculator at WinAging helps with personalized dosing based on body weight.

Use the supplement interaction checker to verify your complete stack doesn't have conflicts before you start. Rapamycin's CYP3A4 metabolism is the biggest interaction risk, but the full picture of your protocol matters.

Frequently asked questions

Can you buy rapamycin without a prescription?

Not legally in the US. Rapamycin requires a valid prescription from a licensed US physician. Off-label prescribing is legal, so any physician can write that prescription based on their clinical judgment. Telehealth platforms have made this more accessible than ever. Importing without a prescription from overseas is technically illegal, and the quality of offshore sources is unreliable enough that even people who accept the legal risk often end up with a product that contains no detectable drug.

How much does rapamycin cost per month for longevity use?

At a typical dose of 5mg once per week, you use roughly 4-5 tablets per month. With GoodRx on generic sirolimus, expect to pay approximately $12-25/month for the drug alone. Cost Plus Drugs is often cheaper. Telehealth platforms that bundle consultation, labs, and medication run $64-149/month. Compounding pharmacies for custom dose capsules typically charge $80-120/month.

What's the difference between rapamycin and sirolimus?

They're the same drug. Sirolimus is the generic chemical name. Rapamycin is the original name from its discovery. Rapamune is Pfizer's brand-name version. Generic sirolimus is significantly cheaper and available at all major US pharmacies with a valid prescription.

Do I need bloodwork before starting rapamycin?

Yes, and any physician who takes this seriously will require it. Minimum panel: fasting lipid profile, fasting glucose and HbA1c, complete blood count, and comprehensive metabolic panel. Ongoing monitoring every 3-6 months is standard practice to catch any lipid or glucose changes early.

How long before rapamycin has measurable effects?

Cellular effects (mTOR inhibition, autophagy activation) happen within hours of dosing. Observable changes in inflammatory biomarkers or other longevity markers typically appear over weeks to months of consistent use. The PEARL trial ran 48 weeks to capture meaningful health metrics. Think in terms of months and years, not days.

Can rapamycin reverse aging?

Not reverse in the sense of undoing existing damage entirely. What rapamycin does is slow the progression of several aging mechanisms simultaneously. The mouse data shows life extension. The human data shows healthspan improvements. It's a maintenance and slowing compound, not a reset. The distinction matters for setting realistic expectations.

Is rapamycin safe for everyone over 40?

Not without evaluation. People who are pregnant or trying to conceive, have active serious infections, have severe kidney or liver disease, or have surgery planned in the near term should not take rapamycin. Anyone taking drugs that interact with CYP3A4 needs a careful medication review first. Everyone needs baseline bloodwork. "Over 40 and interested in longevity" is a starting point for a conversation with a physician, not a sufficient qualifier on its own.

What happens if I miss a dose?

Weekly pulse dosing allows some flexibility. Missing one weekly dose is not a crisis. Simply continue on your normal schedule the following week. Don't double up. The weekly rhythm is designed to allow full mTOR recovery between doses, so missing one week doesn't undo the protocol.

Want a personalized stack tailored to your goals? Try the AI protocol builder to get a custom longevity protocol in minutes.

Related guides

• What to avoid when taking low dose naltrexone
• Best berberine supplement: the mTOR-adjacent option
• Resveratrol or NMN: choosing your longevity stack
• Glycine dosage for anti-aging
• Check your supplement interactions

Sources

• Rapamycin fed late in life extends lifespan in genetically heterogeneous mice, Harrison et al., Nature (2009)
• PEARL trial: influence of rapamycin on safety and healthspan metrics after one year
• Rapamycin for longevity: pros, cons, and future perspectives, Frontiers in Aging (2025)

---

Rapamycin is the most scientifically credible pharmacological longevity intervention that exists right now. The animal data is extraordinary. The human safety profile at pulse doses is acceptable. And the access question, the one that used to be a barrier, is largely solved. Telehealth platforms, generic sirolimus pricing, and compounding pharmacy options have made this accessible to anyone who takes the time to navigate the process properly.

What that process requires: a baseline blood panel, a telehealth consultation with a platform that does this responsibly, a physician who understands pulse versus daily dosing, and a commitment to ongoing monitoring. That's the whole thing. It's not complicated. It just requires doing it right.

Use the free tools at WinAging to track your biomarkers, check your full stack for interactions, and establish the biological age baseline you'll measure your progress against. The data you collect now is how you'll know, months from now, whether your protocol is actually working.